x

Search for a research project

* (*) mandatory field

56 Result(s)

Sort by

Funded by an IRDiRC member = Member of a ERN =

Research projects

PORTUGAL

SUL
LISBOA

Do miRNAs and TAL1 crosstalk? New insights into the regulation and function of a major T-cell oncogene
Faculdade de Medicina da Universidade de Lisboa
Unidade de Biologia do Cancro

SPAIN

Madrid
CANTOBLANCO

Novel immunotherapeutic strategies against T-ALL, a rare pediatric disease
CBMSO - Centro de Biología Molecular Severo Ochoa
Desarrollo del sistema linfohematopoyético humano

AUSTRIA

WIEN
WIEN

Find tumor immune evasion strategies by cellular barcoding
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

CDK8 - a weapon to arm NK cells against leukemia
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

FINLAND

Finland
KUOPIO

FINLAND

Finland
TAMPERE

Funded by an IRDiRC memberGenomics based tools for personalized treatment in pediatric cancer (GEPARD)
TAYS - Tampere University Hospital
Lasten hematologian ja onkologian osasto

FINLAND

Finland
TAMPERE

Funded by an IRDiRC memberNovel targeted therapies for acute leukemias
Tampere University
Tampere Center for Child Health Research

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Bayern
ERLANGEN

Late Effects Surveillance System (LESS) for oncological diseases in children und adolescents
Kinder- und Jugendklinik des Universitätsklinikums Erlangen
Kinder- und Jugendklinik

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

Funded by an IRDiRC memberTurbiCAR: UniCAR-based therapy of CD123-positive leukemias
Institution: Information not provided - DE

GERMANY

Berlin
BERLIN

ALL-REZ BFM: Observational study biobank for children with Acute Lymphoblastic Leukemia
Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie

GERMANY

Berlin
BERLIN

Funded by an IRDiRC memberIRMA-4-ALL: Measurement of individual therapy response of acute lymphoblastic leukemias
Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie

GERMANY

Niedersachsen
HANNOVER

ITALY

EMILIA ROMAGNA
MELDOLA

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

PORTUGAL

NORTE
PORTO

Clinical implications of activation of PI3K/Akt signaling pathway in primary adult acute lymphoblastic leukemia.
Hospital de Santo António - Centro Hospitalar do Porto
Unidade de Imunologia Clínica

PORTUGAL

SUL
LISBOA

SPAIN

Cataluña
BADALONA

Treatment of BCR-ABL Negative ALL in Adults According to MRD and Genetics - ES
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Hematología Clínica

SPAIN

País Vasco
BARAKALDO

New pharmacogenomic signature of treatment response prediction by studying non-coding RNAs in leukemia
Instituto de Investigación sanitaria Biocruces Bizkaia
Grupo de investigación en oncología pediátrica

SWEDEN

Region Skåne
LUND

Hematopoietic stem cell proliferation in development and in acute lymphoblastic leukemia
Lund University
Department of Experimental Medical Science

SWEDEN

Region Stockholm
STOCKHOLM

Transcriptional mechanisms by Notch and E2A proteins in lymphocyte development and ALL
Karolinska Institutet - Solna
The Institute of Environmental Medicine

SWITZERLAND

Suisse Alémanique
ZÜRICH

Niche-based modeling and therapeutic targeting of highly resistant acute lymphoblastic leukemia
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberBiomarkers of vincristine-induced peripheral neuropathy
Institution: Information not provided - US

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

GERMANY

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

SWITZERLAND

Suisse Romande
LAUSANNE

Deciphering the impact of chromosomal alterations on genome topology of lymphoma
EPFL - Ecole Polytechnique Fédérale de Lausanne
ISREC Institut Suisse de Recherche Expérimentale sur le Cancer - Elisa Oricchio Lab

SWITZERLAND

Suisse Alémanique
ZÜRICH

The Swiss Pediatric Hematology/ Oncology Metabank - a network for precision medicine research
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

AUSTRIA

WIEN
WIEN

Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Funded by an IRDiRC memberEuropean Reference Network on Paediatric Cancer Connecting Facility 2 - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Funded by an IRDiRC memberERN-PAEDCAN Partner: Paediatric Rare Tumours Network - European Registry [PARTNER] - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

CANADA

Ontario
TORONTO

FRANCE

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

GERMANY

Baden-Württemberg
HEIDELBERG

Funded by an IRDiRC memberERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

ITALY

VENETO
PADOVA

Funded by an IRDiRC memberModulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Multicentric Research projects